Universe Pharmaceuticals Files $200M Shelf and Registers 87% of Outstanding Shares for Resale
UPC has more than doubled off its 52-week low of $2.
Summary
Universe Pharmaceuticals registered a $200M universal shelf and 4.38M shares for resale by selling shareholders, representing ~87% of outstanding Class A shares. The filing also discloses a new Nasdaq delisting risk tied to a $5M minimum market value rule.
Key Events · Financing and Capital Events · UPC
-
$200M Universal Shelf Registered
The company registered up to $200 million of Class A ordinary shares, debt securities, warrants, rights, and units for sale from time to time.
-
87% of Outstanding Shares Registered for Resale
4,376,552 Class A ordinary shares held by selling shareholders were registered for resale, representing approximately 87.39% of the 5,008,313 Class A shares outstanding.
-
Substantial Overhang on Stock
The resale registration creates a significant overhang that could depress the stock price for an extended period, regardless of whether the selling shareholders actually sell.
-
Nasdaq Delisting Risk Disclosed
A new Nasdaq rule requiring a $5 million minimum market value could result in immediate delisting with no cure period if implemented; the rule is currently suspended pending SEC review.
Analysis · UPC · Life Sciences
Universe Pharmaceuticals filed a new $200 million universal shelf registration and registered 4,376,552 Class A ordinary shares for resale by selling shareholders — approximately 87.39% of the company's outstanding Class A shares. The resale registration creates a substantial overhang: even modest sales by the selling shareholders could have an outsized impact on the stock price given the company's limited trading volume. The filing also discloses a new Nasdaq minimum market value rule that, if implemented, could result in immediate delisting with no cure period — a material governance and listing risk for a company with a market cap of approximately $22.7 million.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 48.2% of the 1980 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.20%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, UPC was trading at $4.52 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $22.7M. The 52-week trading range was $2.00 to $17.96. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.